Viewing Study NCT02880293


Ignite Creation Date: 2025-12-25 @ 1:16 AM
Ignite Modification Date: 2026-02-20 @ 10:57 PM
Study NCT ID: NCT02880293
Status: COMPLETED
Last Update Posted: 2024-12-06
First Post: 2016-08-23
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Haploidentical (Half-matched) Related Donor Stem Cell Transplantation Using Killer Immunoglobulin-like Receptors in Addition to Normal Selection Factors to Determine the Best Donor
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2016-08-23
Start Date Type: None
Primary Completion Date: 2023-11-20
Primary Completion Date Type: ACTUAL
Completion Date: 2023-11-20
Completion Date Type: ACTUAL
First Submit Date: 2016-08-23
First Submit QC Date: None
Study First Post Date: 2016-08-26
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2024-11-11
Results First Submit QC Date: None
Results First Post Date: 2024-12-06
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-11-11
Last Update Post Date: 2024-12-06
Last Update Post Date Type: ACTUAL